Filing Details
- Accession Number:
- 0001415889-20-003015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-22 19:31:43
- Reporting Period:
- 2020-12-18
- Accepted Time:
- 2020-12-22 19:31:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697362 | Burkes Michael Brophy | C/O Natera, Inc. 201 Industrial Road Suite 410 San Carlos CA 94070 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-12-18 | 12,500 | $0.00 | 71,183 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-12-21 | 1,117 | $0.00 | 72,300 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-12-22 | 5,208 | $105.48 | 67,092 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2020-12-18 | 12,500 | $0.00 | 12,500 | $0.00 |
| Common Stock | Restricted Stock Unit | Disposition | 2020-12-21 | 1,117 | $0.00 | 1,117 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,000 | No | 4 | M | Direct | ||
| 1,118 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting on September 19, 2019.
- Each RSU represents a contingent right to receive one share of the common stock of the issuer.
- Represents the partial vesting and settlement of RSUs, starting on March 21, 2018.
- The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs.
- On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On December 18, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.
- The RSU vest over four years. 25% of the RSUs vest on March 21, 2018 and the remaining shares vest in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
